AstraZeneca PLC (AZN) released earnings for its first quarter that Increases, from the same period last year
The company's bottom line totaled $3.081 billion, or $1.97 per share. This compares with $2.921 billion, or $1.87 per share, last year.
Excluding items, AstraZeneca PLC reported adjusted earnings of $2.58 per share for the period.
The company's revenue for the period rose 12.5% to $15.288 billion from $13.588 billion last year.
AstraZeneca PLC earnings at a glance (GAAP) :
-Earnings: $3.081 Bln. vs. $2.921 Bln. last year.-EPS: $1.97 vs. $1.87 last year.-Revenue: $15.288 Bln vs. $13.588 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.